Tag: Cancer research

New Orleans was abuzz last year as hundreds of people gathered to listen to Peter Marks, the head of biologics at the Food and Drug Administration, speak at the American Society of Gene and...

So, like, this dude Angus Chen, right? He's all about cancer stuff - drugs, policy, science, equity, you name it. He hopped on board with STAT in 2021 after doing health and science reporting...

So, like, you know when cancer decides to make a comeback after you thought you were done with it? Doctors call that a recurrence or recurrent cancer. It's like, finding out that cancer is...

In a ground-breaking study, scientists have discovered a new aspect of CAR-T cell therapy that could revolutionize cancer treatment. This innovative therapy involves engineering immune T cells with a synthetic protein known as the...

David Epstein, who previously served as the CEO of Seagen, has launched a new cancer startup called Ottimo Pharma. The company aims to develop a drug that targets two proteins, PD-1 and VEGF, in...

President Joe Biden is focusing on his administration's "moonshot" initiative to reduce cancer deaths as he nears the end of his term. He plans to cut U.S. cancer fatalities by 50% over the next...

The U.S. Food and Drug Administration (FDA) recently approved a new drug for certain adult patients with endometrial cancer. The drug, called Jemperli (dostarlimab-gxly), is an immunotherapy-based drug made by British pharmaceutical company GSK....

The United States spends a significant amount of money on cancer screening each year, with estimates showing that $43 billion was spent in 2021 alone. This cost is attributed to screening for five specific...

Good morning, this is Jonathan Wosen, reporting on the latest news in the biotech and life sciences world. The FDA has recently approved a new treatment for a rare soft tissue cancer. This cutting-edge...